31 – 40 of 2282
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
- Contribution to journal › Article
-
Mark
A non-genotoxic stem cell therapy boosts lymphopoiesis and averts age-related blood diseases in mice
- Contribution to journal › Article
-
Mark
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008–2021 from the Swedish myeloma registry
- Contribution to journal › Article
-
Mark
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
- Contribution to journal › Article
-
Mark
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease : A Systematic Review and Pharmacovigilance Update
- Contribution to journal › Article
-
Mark
Hypogammaglobulinemia at Diagnosis is Associated With Inferior Survival and Higher Risk of Infections in Diffuse Large B Cell Lymphoma
- Contribution to journal › Article
-
Mark
Limited stage mantle cell lymphoma : A real-world study of primary treatment and prognosis in Sweden 2006–2018
- Contribution to journal › Letter
-
Mark
When is ABO-incompatible plasma safe to transfuse? : Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products
- Contribution to journal › Scientific review
-
Mark
Venous thromboembolism in children with Hodgkin lymphoma – A population-based study in Sweden, Finland, and Denmark
- Contribution to journal › Article
-
Mark
Contact activation of coagulation in newly inserted indwelling catheters
- Contribution to journal › Article
